EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C4H5N4O3S2.Na |
| Net Charge | 0 |
| Average Mass | 244.233 |
| Monoisotopic Mass | 243.97008 |
| SMILES | CC(=O)Nc1nnc(S([NH-])(=O)=O)s1.[Na+] |
| InChI | InChI=1S/C4H6N4O3S2.Na/c1-2(9)6-3-7-8-4(12-3)13(5,10)11;/h1H3,(H3,5,6,7,9,10,11);/q;+1/p-1 |
| InChIKey | MRSXAJAOWWFZJJ-UHFFFAOYSA-M |
| Roles Classification |
|---|
| Applications: | antiglaucoma drug Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye. anticonvulsant A drug used to prevent seizures or reduce their severity. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| acetazolamide sodium (CHEBI:31163) has part acetazolamide (CHEBI:27690) |
| acetazolamide sodium (CHEBI:31163) has part acetazolamide(1−) (CHEBI:50634) |
| acetazolamide sodium (CHEBI:31163) has role anticonvulsant (CHEBI:35623) |
| acetazolamide sodium (CHEBI:31163) has role antiglaucoma drug (CHEBI:39456) |
| acetazolamide sodium (CHEBI:31163) is a organic sodium salt (CHEBI:38700) |
| IUPAC Name |
|---|
| sodium [(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonyl]azanide |
| Synonyms | Source |
|---|---|
| Acetazolamide sodium salt | ChEMBL |
| N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide monosodium salt | ChemIDplus |
| Sodium acetazolamide | ChemIDplus |
| Vetamox | ChEMBL |
| Brand Name | Source |
|---|---|
| Diamox | DrugBank |